Equipping living cells with logic gates to fight cancer
Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.
How should we prioritize patients waiting for kidney transplants?
A comprehensive study of the U.S. system could help policymakers analyze methods of matching donated kidneys and their recipients.
Restoring healthy gene expression with programmable therapeutics
CAMP4 Therapeutics is targeting regulatory RNA, whose role in gene expression was first described by co-founder and MIT Professor Richard Young.
New initiative to advance innovations in pediatric care
The Hood Pediatric Innovation Hub aims to break down barriers to pediatric innovation and foster transformative research to improve children’s health outcomes.
Could LLMs help design our next medicines and materials?
A new method lets users ask, in plain language, for a new molecule with certain properties, and receive a detailed description of how to synthesize it.
Engineers develop a better way to deliver long-lasting drugs
With tinier needles and fewer injections, the approach may enable new options for long-term delivery of contraceptives or treatments for diseases such as HIV.
Study: Tuberculosis relies on protective genes during airborne transmission
The findings provide new drug targets for stopping the infection’s spread.
Designing better ways to deliver drugs
Graduate student and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.
Faces of MIT: Michele David
The chief of clinical quality and patient safety at MIT Health says her job allows her to use her entire skill set.
A protein from tiny tardigrades may help cancer patients tolerate radiation therapy
When scientists stimulated cells to produce a protein that helps “water bears” survive extreme environments, the tissue showed much less DNA damage after radiation treatment.
MIT spinout maps the body’s metabolites to uncover the hidden drivers of disease
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
MIT class takes students on a grand tour of the interdisciplinary world of biotech
Exploring and applying concepts from different disciplines provides broad knowledge and hands-on practice for real-world application.
Can deep learning transform heart failure prevention?
A deep neural network called CHAIS may soon replace invasive procedures like catheterization as the new gold standard for monitoring heart health.
Is this the new playbook for curing rare childhood diseases?
When his son received a devastating diagnosis, Fernando Goldsztein MBA ’03 founded an initiative to help him and others.
Toward video generative models of the molecular world
Starting with a single frame in a simulation, a new system uses generative AI to emulate the dynamics of molecules, connecting static molecular structures and developing blurry pictures into videos.